Zhejiang Jolly Pharmaceutical Hits Day High with Strong 5.67% Surge

Zhejiang Jolly Pharmaceutical Co., Ltd. has experienced a notable increase of 5.67% on June 23, 2026, reaching an intraday high of CNY 13.80. This performance stands in contrast to the broader market, as the China Shanghai Composite index declined by 1.37% on the same day. Over the past week, Zhejiang Jolly has shown a positive trend with a gain of 3.42%, while the Shanghai Composite managed only a modest increase of 0.35%. However, the stock's performance over the past month reflects a decline of 4.29%, and it has faced a more significant drop of 18.89% over the past year, contrasting sharply with the Shanghai Composite's gain of 21.43%. Despite these fluctuations, the company maintains a solid financial position with a return on equity of 19.30% and a price-to-book ratio of 2.76. Additionally, it offers a competitive dividend yield of 2.59%. With a market capitalization of CNY 9,462 million, Zhejiang Jolly continues to navigate the pharmaceuticals and biotechnology sector amid varying market conditions.